Review
Jul 2026
Neoadjuvant therapy for NSCLC: From monotherapy to precision combination therapy.
The CheckMate-816 trial confirmed that nivolumab plus chemotherapy outperforms chemotherapy alone, but there are still several challenges in neoadjuvant therapy.
Qianshuo Mao, H. Mo, Kai-Shan Zhang et al.
· Critical reviews in oncology... · 0 citations